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Supplemental Methods:
Plasmids and Morpholinos
CCDC78 was amplified by PCR from Xenopus cDNA using the primers 5'-GCGGATCCATGGATTCTACAGAAGATCG-3' and 5'-CGCTCGAGACATCTCATGGCTGTTTC-3' and cloned into pCS2+ using BamHI and XhoI and was N-terminally fused to GFP or RFP.
Cep152 (Unigene Xl.13956) was amplified from an Open Biosystems clone using primers 5'-CCATCGATGTTCTATCGACTTTGATAGTGGAGCACTGCAGACT-3' and 5'-CCATCGATTTAGTTGAAGTTATTTAAGTTGGGAAATGGGCT6GTC-3' and cloned into pCS2+
using ClaI and N-terminally fused to RFP. Sas6 (Unigene Xl.33005) was amplified from
Xenopus cDNA using primers 5'-GCGAATTCATGGCCGACGAGTTGTTC-3' and 5'-GCCTCGAGGGAAGCAGGAAGCCTGG-3' and cloned into pCS2+ using EcoRI and XhoI and was N-terminally fused to RFP. Plk4 (Unigene Xl.56605) was amplified by PCR from Xenopus cDNA using the primers 5'-GCGAATTCATGGGGGGCAGCATAGG-3' and 5'-GCTCTAGAGCGACTGGACGAGCTGG-3' and cloned into pCS2+ using EcoRI and XbaI and Nterminally tagged with GFP. To allow for injection of DNA of this construct the CMV promoter was switched with the α-tubulin promoter. GFP-hCCDC78 (Unigene Hs.381943) was amplified from a clone using primers 5'-GCGAATTCATGGAGCACGCAGCCAC-3' and 5'-GCCTCGAGGGATTTCGTGCTTGTACC-3' cloned into pCS2+ using EcoRI and XhoI and Nterminally tagged with GFP or RFP. For mammalian cell transfections, RFP-CCDC78 was cut out with HindIII and XbaI and ligated into EGFP-N1 that was also digested with HindIII and XbaI to remove the GFP. All cloning was verified by sequencing.
Morpholino antisense oligonucleotides (GeneTools) were injected into two-or fourcell stage embryos to inhibit the expression of Xenopus CCDC78 (Unigene Xl.4890) (Nasevicius and Ekker, 2000) . One morpholino was used to target CCDC78 at the initiation site or a splice site: Initiation Site: 5'-CATCAGTGTTACTAGGATAGGCAGG-3'; Splice Site: 5'-TTATATCCTTACTCCTACCTTTAGT-3'. Morpholinos were injected into each quadrant of the animal pole at the two-or four-cell stage using a total of 50-75ng per embryo. 
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